# Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

> **NCT00993655** · PHASE2 · COMPLETED · sponsor: **Canadian Cancer Trials Group** · enrollment: 275 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Metastatic Cancer
- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00993655
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-03
- **Primary completion:** 2016-03-10
- **Final completion:** 2016-07-11
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2023-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00993655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00993655, "Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00993655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*